日期: 2025年1月25日

SHENZHEN, CHINA, Jan 24, 2025 - (ACN Newswire via SeaPRwire.com) - China Medical System Holdings Limited (the “Company”, together with its subsidiaries, the “Group” or “CMS”) is pleased to announce that on 24 January 2025, the Group through subsidiaries of the Company entered into a Collaboration Agreement with Hunan Mabgeek Biotechnology Co., Ltd. (“Mabgeek Biotechnology”) and its subsidiary for Class 1 innovative drug anti-IL-4Rα humanized monoclonal antibody injection MG-K10 (“MG-K10” or the “Product”). The Group has obtained the co-development right as specifically agreed upon in the Agreement and exclusive commercialization right to the Product in Mainland China, Hong Kong Special Administrative Region, Macao Special Administrative Region, Taiwan Region and Singapore (the “Territory”); Mabgeek Biotechnology will support the commercialization activities and is responsible for the sale and supply of the Product. The collaboration term is perpetual.IL-4Rα is considered a key target for the treatment of type 2 inflammatory diseases, such as atopic dermatitis (AD), asthma, prurigo nodularis, etc. Anti-IL-4Rα monoclonal antibodies are among the best-selling biologics in this field. MG-K10 is an innovative long-acting anti-IL-4Rα humanized monoclonal antibody that simultaneously blocks the signaling of key type 2 inflammatory cytokines IL-4 and IL-13. Following Fc mutation, MG-K10 allows long dosing interval owing to its prolonged half-life, and it is expected to be the first long-acting anti-IL-4Rα monoclonal antibody marketed in China. Currently marketed anti-IL-4Rα drugs require dosing every two weeks, whereas MG-K10 only requires dosing every four weeks, demonstrating good efficacy and safety. MG-K10 has the potential to be the Best-in-Class (BIC).This collaboration marks another significant milestone for Dermavon (formerly known as CMS Skinhealth)’s layout in the dermatology field. MG-K10 will enrich the global differentiated innovative pipeline of Dermavon, and will strongly synergize with the existing product portfolio, such as marketed innovative drug ILUMETRI (tildrakizumab injection), marketed exclusive drug Hirudoid (mucopolysaccharide polysulfate cream) and dermatology-grade skincare products of Heling soothing product series (developed for AD patients), and innovative pipeline drugs ruxolitinib cream (for the topical treatment of mild to moderate AD and non-segmental vitiligo) and povorcitinib (for the treatment of non-segmental vitiligo, hidradenitis suppurativa, prurigo nodularis and chronic spontaneous urticaria), etc. Leveraging its proven clinical development and commercialization capabilities, the Group will fully cooperate with Mabgeek Biotechnology to promote the approval of MG-K10 in China, bringing a new treatment option with lower dosing frequency, good efficacy and safety to patients with type 2 inflammatory diseases in China.More information about MG-K10MG-K10 is a Class 1 innovative drug anti-IL-4Rα humanized monoclonal antibody injection that used for the treatment of type 2 inflammatory diseases, including AD, asthma, prurigo nodularis, allergic rhinitis, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, chronic obstructive pulmonary disease and so on. It holds substance patents in specific countries/regions within the Territory.MG-K10 has entered Phase III clinical trials in China for AD, asthma, and prurigo nodularis. In the completed Phase II clinical trials for adult moderate-to-severe AD and moderate-to-severe asthma, MG-K10 has demonstrated good efficacy and safety[1-2]. Additionally, MG-K10 has obtained IND approval for eosinophilic esophagitis, chronic rhinosinusitis with nasal polyps, and seasonal allergic rhinitis in China.According to Frost & Sullivan, the global market for treatments targeting IL-4Rα is expected to reach US$28.7 billion by 2030, with a compound annual growth rate (CAGR) of 21.8% from 2020 to 2030. In China, the market is projected to reach US$4.08 billion by 2030, with a CAGR of 76.8% from 2020 to 2030.About AD indicationMG-K10’s first indication, AD, is a chronic inflammatory skin condition characterized by severe itching. It is the most burdensome non-fatal skin disease globally, with at least 230 million people affected worldwide[3]. AD is also a prevalent and high-burden chronic disease in China, with the prevalence showing an upward trend[3]. According to the Global Burden of Disease Study 2019, the number of AD patients in China increased by 25.65% from 1990 to 2019[3]. It is estimated that there are approximately 36.09 million AD patients in China[3], with approximately 9.625 million suffering from moderate-to-severe AD[4].Current treatment options for AD primarily include topical and systemic treatments. For moderate-to-severe AD, topical medications are often insufficient to achieve disease control, necessitating the initiation of systemic treatments. However, due to the limitations in efficacy and safety of traditional systemic therapies for AD, moderate-to-severe AD patients often experience delays in systemic treatment initiation, poor compliance, and suboptimal disease control, leaving a significant unmet need in clinical practice[3]. MG-K10, with its extended dosing interval of once every four weeks, is expected to improve patient adherence and provide a new, effective, and safe systemic treatment option for patients with moderate-to-severe AD.About Mabgeek BiotechnologyMabgeek Biotechnology was founded in 2016 and has always adhered to the research and development concept of “innovation, efficiency and safety”, focusing on the fields of allergic inflammatory diseases and autoimmune diseases. Mabgeek Biotechnology is equipped with a research and development team composed of top industry experts. With excellent research capabilities and deep industry experience, Mabgeek Biotechnology uses its unique TEADA high-throughput antibody screening platform to develop innovative antibody drugs with high biological activity, excellent druggability, and differentiation. Mabgeek Biotechnology is committed to providing safer, more effective and more convenient treatment solutions for patients worldwide. For more information about Mabgeek Biotechnology and its products, please visit: https://www.mabge.com/.About CMSCMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development of its advantageous specialty fields and expand business boundaries. While strengthening the competitiveness of the cardio-cerebrovascular/gastroenterology business, CMS independently operates its dermatology and medical aesthetics business, and ophthalmology business, aiming to gain leading positions in specialty therapeutic fields, whilst enhancing the scale and efficiency. At the same time, CMS has expanded its business territory to the Southeast Asian market, striving to become a “bridgehead” for global pharmaceutical companies to enter the Southeast Asian market, further escorting the sustainable and healthy development of the Group.Reference:1. The data of the product’s Phase II clinical trial for AD indication as disclosed by Mabgeek: https://www.mabge.com/en/index.php?c=show&id=232. The interim data of the product’s Phase II clinical trial for asthma indication as disclosed by Mabgeek: https://www.mabge.com/index.php?c=show&id=183. Chinese Society of Dermatology, China Dermatologist Association. Clinical pathway for the diagnosis and treatment of moderate to severe atopic dermatitis in China (2023): an expert consensus[J]. Chinese Journal of Dermatology, 2023, 56(11): 1000-1007. DOI: 10.35541/cjd.20230247.4. Mao, Dandan et al. Prevalence and risk factors of atopic dermatitis in Chinese adults: a nationwide population-based cross-sectional study. Chinese medical journal vol. 136,5 604-606. 5 Mar. 2023, DOI:10.1097/CM9.0000000000002560CMS Disclaimer and Forward-Looking StatementsThis press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsWebsite: https://web.cms.net.cn/en/home/Source: China Medical System Holdings Ltd. Copyright 2025 ACN Newswire via SeaPRwire.com.

SINGAPORE, Jan 24, 2025 - (ACN Newswire via SeaPRwire.com) - Tired of random DMs, awkward intros, or shallow connections? Viberse, the social app for connecting with people through sharing glimpses of life, introduces Tango—a fun, daily mission designed to help users break the ice and make new friends worldwide.The new Tango tab features Bingo Tango, a fresh twist on bingo, where users share their daily lives through photos or videos to unlock the ability to chat directly via messaging.https://youtube.com/shorts/sHaJ4SS2U5w?si=JHL6alkDofT-hxKnThink of Bingo Tango as bingo reimagined; instead of numbers on cards, it connects people through shared moments. Whether it’s posting your “(CoffeeRun) OTD” or reminiscing with “BackTo (FirstConcert),” Tango turns everyday stories into conversations and friendships.According to Viberse, the name “Bingo Tango” captures the collaboration and back-and-forth rhythm needed for two people to connect. Like a dance, partners take turns sharing moments, creating a natural flow. Once a bingo is scored—completing the mission—the two users unlock chat to connect deeper.A new, fun way to socializeTango isn’t just a feature—it’s a new way to socialize. By teaming up to share on the same topics, users create mutual vibes and meaningful bonds. Completing 6 posts across 3 matching topics finishes the Bingo Tango mission and unlocks a direct chat.Bingo Tango, a daily mission to befriend people. COURTESY OF VIBERSEAt its core, Tango is about building connections through shared content and collaboration. Unlike random DMS, every connection on Viberse starts with teamwork and mutual vibes, making each connection meaningful and genuine.“You never know who you’ll pair up with, what topics they’ll choose, or the stories they’ll share,” says the Viberse team. “This unpredictability, combined with authentic exchanges, makes socializing on Viberse exciting, genuine, and personal.”Tango redefines socializing by turning everyday stories into steps toward new friendships. Purposeful, playful, and deeply personal, it’s perfect for anyone ready to connect beyond the ordinary.About ViberseFounded in 2024 in Singapore, Viberse Technology is creating a platform where users can explore the extraordinary within everyday life, share their experiences, and connect meaningfully with others. Viberse offers a more authentic way to socialize in the digital age.Media ContactChristine Linchristine.lin@viberse.com Copyright 2025 ACN Newswire via SeaPRwire.com.

HONG KONG, Jan 24, 2025 - (ACN Newswire via SeaPRwire.com) - Celebrating its 2nd anniversary, Artelli proudly stands as Macau's pioneering multi-dimensional art space, establishing itself as a brand in the art world with a mission to "Anchored in Asia, Connecting the World Through Art". This year's anniversary marks a significant milestone, with Artelli honored by two prestigious awards: the 2024 Asia-Pacific Stevie® Awards for Excellence in Innovation (Bronze) and the Marketing Events Awards Hong Kong 2024 for Best Event in Arts, Leisure and Entertainment (Silver). These accolades not only affirm Artelli's role as a driving force in the arts but also highlight the brand's commitment to opening new perspectives in cultural exchange between Asia and the international community.Bridging borders and art forms with 20+ multicultural art projects across four distinct locationsSince its founding in 2022, Artelli has been passionately dedicated to connecting Asia's art enthusiasts with the global art community. Over the past two years, Artelli has curated more than 20 debut exhibitions across Greater China, showcasing a spirited tapestry of contemporary art, pop art, iconic cross-disciplinary collaborations, and cutting-edge Web 3.0 digital art. These exhibitions have drawn over 6 million visitors and received extensive international media coverage with more than 2,000 mentions in articles. Embraced enthusiastically by the art community, these exhibitions have also paved the way for innovative integration of "Culture + Tourism + Art", marking the unique creative collaboration.In addition, Artelli fosters exclusive collaborations with artists to create original and irresistible art experiences. Artists are invited to Macau early in the planning stages of exhibitions, allowing them to immerse themselves in the city's distinctive cultural landscape. Drawing inspiration from Macau's multicultural heritage, these artists infuse their work with a strong sense of place and purpose, contributing pieces that capture an assertive allure and resonate powerfully with both local and international audiences.Japanese artist Yuya Hashizume explored Macau's vibrant culture before his "eyewater+" debut exhibition, drawing inspiration from the city's signature colors, vermilion red, ink green, and yellow. His Macau-exclusive works were showcased at Artelli.In the convergence of "Art" and "Intelligence", the name Artelli was born. It embodies the brand's commitment to pioneering innovation in art and technology. As a forward-thinking, next-generation art platform, Artelli collaborates with artists to create unique, original content. From initial concept to final presentation, every part of the process is a prodigious endeavor, including creation, curation, exhibition design, artist events, and merchandise. Behind each detail is the work of the Macau-based curatorial team, reflecting the dedication and peerless attention in delivering a fully immersive 360° experience. Artelli is also committed to utilizing diverse resources and actively expanding robust cross-sector collaborations. Through a distinctive curatorial approach that seamlessly integrates art, technology, and the commercial sector, Artelli deepens the impact and reach of the arts, making each exhibition a meaningful testament to the value and potential of art in our modern society.Core Curatorial Team of ArtelliAn immersive art journey curated in three languages, guided by art ambassadorsArtelli's flagship store is located in the heart of Macau's Cotai district, within the spacious confines of The Showroom at City of Dreams. This dynamic, multi-functional space spans 600 square meters across two and a half floors, envisioned by the renowned French interior design agency Malherbe Paris. Tasked with materializing Artelli's vision, the interior is defined as a true artistic canvas, reflecting the fluidity of natural landscapes to complement all forms of art. With a pure white palette, the layout features an open, interwoven structure that harmoniously reveals distinct zones. Visitors journey along the immersive viewing path, as if they are walking through a modern art sanctuary, watching each artwork unfold dynamically with shifts in time and perspective. To elevate art experience, Artelli also offers guided tours in three languages, instilling visitors with the stories behind the artworks and insights into the creative visions of each artist, reimagining cross-cultural connections in its spirits of innovation.Artelli’s vision for the future sees abundance opportunities for innovation in the sustainable development of artFor over 700 days, Artelli has driven curatorial practices with original content, presenting international art projects fueled by the team's passion and expertise. The art space has emerged as a rising star in the global art scene.Looking ahead, Artelli is committed to pursue innovations in art, curating groundbreaking global art projects and empowering culture through transformative art education by hosting masterclasses, academic forums, and workshops to broaden public access to art. Through comprehensive, one-stop curation and project management, Artelli strives to establish itself as an international landmark for art and culture that connects global and local art communities. Believing in art as a universal language, Artelli sparks conversations that inspire and connect across cultures.In parallel, Artelli is dedicated to nurturing artistic talent in creative processes such as curation, visual arts, and art consultancy, bringing fresh energy to the art ecosystem in Macau and across Asia.As a pioneering art label in Asia, Artelli looks forward to continuing its journey of connecting diverse cultures around the globe through artistic initiatives, transforming art as a universal language that transcends regions and cultures. Artelli aims to bring lasting momentum to the arts and culture scene in Macau and Asia, with a long-term vision of driving sustainable development in the art industry.Featured Highlight Projects2024 | City of Dreams and Artelli Jointly Presented The "Crowning Journey of Jean-Michel Basquiat"Artelli and City of Dreams proudly presented Legendary artist Jean-Michel Basquiat's "Crowning Journey" across four major areas at City of Dreams Macau: The Main Portal, Southwest Entrance (outdoor area), The Showroom, and Artelli – The Pioneering Multi-dimensional Art Space. Large-scale installations, multimedia, immersive and interactive multi-dimensional experiences took the audience on an unprecedented journey, inviting them to explore the thoughts and ideas of Jean-Michel Basquiat.For the event, a series of merchandise that references Basquiat's powerful expressionism was released, including the special edition of Mahjong Set, Art Puzzle, and Postcard set. These products creatively integrate the artist's iconic symbols and creative spirit into everyday life.2024 | Internationally renowned Chinese artist Zhuang Hong-Yi's First solo exhibition in Macau "Shades of Blossoms"In this exhibition, Zhuang Hong-Yi presented his latest 'Flowerbed Series', using delicate Chinese rice paper and thick acrylic pigments of the Western style, to create visually rich and three-dimensional artworks. Zhuang's renowned and highly collectible "Flowerbed Colorchange" stands as a distinctive hallmark of his creations. When viewed from left to right, the artwork appears to change color, and the folded rice paper makes a cohesive piece when experienced up close, revealing a harmonious tapestry of seamlessly blended petal textures. The art space vibrated with the colorful floral elements that reveal a mirror of a flower sea, allowing each viewer to experience an enchanting and immersive scenery change with every step they take.2024 | Renowned Japanese Photography Master Nobuyoshi Araki’s "Paradise", A Collaborative Tribute Between Hong Kong and MacauCelebrating the 84th birthday of the renowned Japanese photography master Nobuyoshi Araki in May, Artelli, presented the "Paradise" showcased in collaboration with venues in Hong Kong and Macau, features over 200 iconic works spanning Araki's four-decade career, paying tribute to him in various ways. "Paradise" Hong Kong POP-UP takes place at CEMENT, the modular creative and community-driven space of K11 MUSEA, and Macau Exhibition located at Artelli with "Darkroom" to offer glimpse into Araki's photographic desires. At the time, highly collectible artist-signed instant photography works in deluxe editions were simultaneously available for purchase in Hong Kong and Macau.2024 | "Viral Code? – A Discussion on Art and the Masses" Zhao Xiaoli and Wu Xixia Dual ExhibitionSupported by the Macau Cultural Development Fund in 2024, the exhibition invited the internationally renowned artist and first Chinese female curator, Ms. Victoria Lu, as its academic advisor. Together with the two female artists, Zhao Xiaoli and Wu Xixia, they presented a journey of multiple reflections on art, audience engagement, and the identity of female creators. Through the themes explored in their works and their unique artistic perspectives, they conveyed positive messages of diversity and the multifaceted development of the art industry. Not only showcased art creations during the opening ceremony, Zhao Xiaoli and Wu Xixia also collaborated with Ms. Victoria Lu in hosting an art symposium and a fan signing session at Artelli. Together, they engaged the public in discussions about the stories and thoughts behind their creative processes.2024 | New York Artist Adam Handler's Largest Solo Exhibition in Asia "Always near you...Always"New York artist Adam Handler, captivated for his distinctive Kawaii Faux Naïf style, held his largest solo exhibition in Asia at Artelli. Over 100 international collectors and art enthusiasts attended the opening ceremony. The exhibition, themed "Love Heals", showcased Adam Handler's new works and debut creations, including the Ghost Series, the UFO Abduction Series, and the Battle Ground Series.2023 | Mr Doodle First Exhibition in MacaoArtelli, in its capacity as a co-organizer and curator, has presented the "Mr Doodle First Exhibition in Macao" with Melco Resorts & Entertainment. Mr Doodle’s meticulously created artworks could be seen throughout City of Dreams and Artelli, including the iconic public art building "Doodle Showroom" on the Cotai Strip, which reinvented the look of The Showroom with its sleek lines and unique patterns; "Doodle Hall" was a breathtaking immersive exhibition at the main entrance of City of Dreams while "Doodle Love Wall" was set as a large-scale public interactive art installation that launched on China's Valentine's Day; "Doodle Cube" launched as a multimedia art installation at the Morpheus Hotel that blended a distinctive style of graffiti with a free-flowing architectural design. Additionally, the exhibition featured the "Mr Doodle Afternoon Tea Experience" and marked the global debut of the limited-edition "Disney Art Collection by Mr Doodle" at Artelli.2023 | Japan's Legendary Artist Takeru Amano "Attack of Clone Venus" Hong Kong & Macau DebutThis exhibition marked Takeru Amano's first showcase that features 450 NFT digital and physical collectibles, along with sculptures and giant art installations. "Attack of Clone Venus" was inspired by over 1,000 items from Takeru Amano's daily life. The collection showed striking contrasts through its simplicity, minimalistic design, vibrant colors, and saturated hues. Those who purchased the limited art book are entitled to receive a corresponding NFT digital collectible. The art book is a valuable addition and a must-have item for collectors.Hi-res images for download:https://drive.google.com/drive/folders/1mH3r_czDW5qNzyQGc1AtOdGx5hvqHzNJ?usp=sharingAbout ArtelliArtelli is the pioneering multi-dimensional space for contemporary art, lifestyle aesthetics, digital and techno art, art communities, and brand collaborations. The space stands as a new and unprecedented international landmark for art and culture. Artelli will ultimately join forces with over a hundred internationally renowned artists and brand designers to co-create exclusive art projects and debut collections. With a dedicated focus on Web 3.0 digital art and metaverse, Artelli pioneers the exploration of new artistic dimensions. Guided by a strong commitment to become a multi-dimensional art space that fosters collaborations within the art and culture communities, Artelli's visionary path unfolds through the fusion of art, technology, and the dynamic commercial sector.Media Contacts: Marketing | marketing.mcin@forward-fashion.com | (853) 2871 8921 Copyright 2025 ACN Newswire via SeaPRwire.com.

香港, 2025年1月24日 - (亚太商讯 via SeaPRwire.com) - 原创艺术品牌Artelli自澳门启程，秉持"聚焦亚洲，艺术连结世界"的使命，在创立两周年之际获得"2024亚太史蒂夫®奖 - 产业创新卓越奖"铜奖及"2024香港市场推广活动大奖 - 最佳活动（艺术、文化及娱乐类）"银奖。这一双重荣誉，既是对Artelli作为艺术推动者的肯定，也展示了品牌为亚洲和国际文化交流所带来的新视野。跨越地域与艺术形式，于四地呈献逾20场国际多元艺术项目自2022年成立以来，Artelli致力成为亚洲艺术爱好者与国际艺术界的桥梁。过去两年间，Artelli于中港澳台四地策划逾20场首展，展览内容涵盖当代艺术、流行艺术、标志性跨界合作、前沿的Web 3.0数字艺术等多元形式，吸引逾600万人次参观，超过2000篇国际媒体报导，这些展览不仅深受艺术爱好者的热烈反响，更成为探索"文旅+艺术"融合的创新实践。此外，Artelli亦与艺术家共同创作原创艺术内容，邀请艺术家在展览筹备前期亲临澳门，深入感受城市的文化氛围及为展览内容取材。日本艺术家桥爪悠也于"眼泪+"澳门首展前访澳感受文化气息，为展览创作取材以澳门城市色彩：漆红、墨绿、黄色为启迪，特别创作全新作品于Artelli展出。Artelli的品牌名称融合了"Art"（艺术）与"Intelligence"（智慧），体现品牌对于创新艺术与智能的前瞻性探索。作为一个具前瞻性的新一代艺术平台，Artelli与艺术家共同创造独特原创内容。从展览的初始构思到最终落地，涵盖创作、策展、展场规划、艺术家活动、艺术作品交易等，均由澳门策展团队悉心投入每一细节，力求创造出360°的沉浸式观展体验。Artelli更通过资源整合与共享，积极拓展跨界合作强强联手，以独特的艺术、科技与商业结合的跨领域策展方式，创造出丰富的艺术价值。Artelli澳门主要策展团队一步一景设计观展动线 艺术大使提供三语导览Artelli旗舰据点设于澳门路氹城区核心地段──新濠天地The Showroom，占地600平方米的两层半复合空间由国际知名的法国室内设计公司Malherbe Paris操刀，以纯白色为基调，展现开放与独立交错的空间结构。置身于精心规划的观展动线中，观众犹如行走于现代艺术殿堂，体验著作品随时间与视角变化而生动展现的过程。Artelli还特别设有三语导览，为观众提供丰富而深层的艺术解读，从而加深观众对作品与艺术家创作理念的理解，并促进跨文化的深度交流。未来展望：以创新为驱动，推动艺术产业的可持续发展700多天以来，Artelli以原创内容驱动的策展实践，凭借团队对行业的热忱及专业性，呈献国际艺术项目，成为国际艺术界注目的新星。展望未来，Artelli将延续对艺术创新的追求，策划全球首发的艺术项目，并积极促进艺术教育的推广，举办大师班、学术论坛及艺术工作坊，将艺术知识传播至更广泛的公众领域。透过一站式全方位策展及艺术项目统筹，引入及打造国际性文化艺术的地标，并连接国际与本地艺术社群，发挥艺术平台的桥梁作用，促进以艺术作为共通语言的广泛交流与发展。同时，品牌还将重视艺术人才的培养，包括策展、 艺术鉴赏、艺术顾问等领域，为澳门及亚洲地区的艺术生态注入新的活力。作为亚洲艺术创新的先锋品牌，Artelli期待透过不断的艺术实践与国际文化连结，成为一个超越地域与文化的共通艺术语言，为澳门及亚洲的艺术文化带来持续动力，推动艺术产业的可持续发展为长远愿景。【精选亮点项目】2024 | 澳门新濠天地联合Artelli呈献尚．米榭．巴斯奇亚"加冕之旅"Artelli与澳门新濠天地联合在澳门呈献传奇艺术家尚．米榭．巴斯奇亚"加冕之旅"活动，于澳门新濠天地的四大展区精彩呈现，包括主入口、西南门（户外空间）、The Showroom及多维体验艺术空间Artelli，活动以大型艺术装置、多媒体装置、沉浸式多维体验及互动元素等，将巴斯奇亚的经典作品突破画布界限，带来一场前所未有的艺术旅程，让观众一起探索这位艺术巨星的所思所想。此次活动还特别推出一系列启发自巴斯奇亚独特风格的艺术周边产品，包括特别联乘版麻雀套装、艺术拼图及明信片套装等，将巴斯奇亚的经典元素巧妙融入日常生活，为艺术爱好者的生活美学注入艺术氛围，并将这位艺术巨星的创意精神延续到日常的每个瞬间。2024 | 国际级中国艺术家庄红艺澳门首展"春花弄影"本次展览由庄红艺老师带来全新作品花床系列，运用中国轻薄柔软的宣纸，挥洒上西方厚实成形的丙烯颜料，创作出富立体感的视觉，其特有的艺术专利"Flowerbed Colorchange"更是他作品中的独特亮点，从左至右有隐约的色彩渐变，近赏时却又浑然一体。空间设计以花卉元素延伸塑造一片镜面花海，以强烈的视觉方式感受沉浸式移步换景之魅。2024 | 殿堂级日本摄影巨匠荒木经惟"乐园‧花间"港澳联动适逢殿堂级日本摄影巨匠荒木经惟(Nobuyoshi Araki)84岁诞辰，Artelli于港、澳两地联动将带来艺术家横跨四十年创作生涯、逾200幅经典之作，以多种呈现形式致敬经典。香港限定POP-UP设于艺术文化零售地标K11 MUSEA的全新艺术及文化创意空间CEMENT，澳门站设于Artelli，打造"安全灯暗房"窥探巨匠真挚情感；此外，两地同时推出极具收藏价值的荒木经惟亲签即影即有作品精装予选购收藏。2024 | "流量密码？──艺术与大众的讨论"赵小黎、吴析夏双个展作为2024年澳门文化发展基金支持专案之一，展览邀请享誉国际的首位华裔女性策展人兼艺术家陆蓉之老师担任学术指导，与两位女艺术家赵小黎和吴析夏呈现一场对艺术、对流量、对身为女性创作者的多重思考之旅；透过她们在作品中探索的议题及独有的艺术角度，带出艺术行业的多元化包容及多面向发展的正面信息。两位艺术家除了于开幕仪式上现场表演行为艺术创作，更与陆蓉之老师一起在Artelli进行艺术座谈会及粉丝签名会，与大众一起探讨艺术家们创作背后的故事与思考。2024 | 纽约艺术家亚当-汉德勒(Adam Handler)亚洲最大个展"在你身边，你在身边"纽约艺术家亚当-汉德勒(Adam Handler)以其独特的童趣式疗愈风格闻名，于Artelli举行其亚洲地区至今最大型个展，逾百位国际藏家及艺术爱好者出席开幕式交流互动。是次展览以"Love Heals"为主题，呈现汉德勒全新及首次展出的创作，包括小精灵系列、UFO绑架系列及战斗系列。2023 | Mr Doodle（涂鸦先生）澳门首展Artelli以联合主办及策展单位身份，携手新濠博亚娱乐于国际艺术盛会"艺文荟澳2023"呈献国际知名艺术家Mr Doodle（涂鸦先生）澳门首展，邀请Mr Doodle首次亲临澳门进行现场创作。展览内容包括路氹金光大道地标建筑公共艺术"Doodle Showroom"、以流畅的线条和独特的图案重塑了The Showroom的外观、在新濠天地主入口打造震撼的沉浸式展品"涂鸦殿堂"；于七夕情人节限时推出大型公众互动艺术装置"爱的涂鸦墙"、于摩珀斯酒店大堂展示的以独特的涂鸦风格与流动的建筑设计相结合的多媒体艺术装置“涂鸦魔方”。同时，展览亦带来Mr Doodle下午茶体验，并将迪士尼艺术系列"Disney Art Collection by Mr Doodle"限量艺术藏品于Artelli全球首发。2023 | 日本殿堂级艺术家天野タケル"克隆维纳斯奇袭意境"港澳首展展览聚焦日本人气艺术家天野タケル以其最具代表性的《维纳斯》系列作发想而打造的《克隆维纳斯》全新系列 ── 推出首批共450幅NFT数字藏品及实体作品、立体雕塑、场景艺术装置及大型艺术装置，以虚实交互带给观者创新艺术体验。当传统艺术作品走进Web3.0与元宇宙的虚拟世界，艺术作品不再局限于实体收藏，亦为艺术爱好者提供了数字藏品形式的选择。高清图片下载：https://drive.google.com/drive/folders/15w-zbXmah2HnyktPACjHVy7obFvUDzzk?usp=drive_link关于ArtelliArtelli集当代艺术、生活美学、数码及科技艺术、艺文社群、品牌联乘于一体，是独一无二的多维体验艺术空间。携手过百位蜚声国际的艺术家及品牌设计师，共同创作独家、首发系列艺术项目及限量收藏品，并陆续推出Web 3.0数码艺术及发展元宇宙艺术领域。以独特的艺术、科技与商业结合的跨领域策展方式，同时联动艺术文化社群，重新诠释多维度艺术体验。传媒查询：尚晋（国际）控股有限公司Marketing | marketing.mcin@forward-fashion.com | (853) 2871 8921 Copyright 2025 亚太商讯 via SeaPRwire.com.